# The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer

> **NCT04558034** · NA · TERMINATED · sponsor: **Parkview Health** · enrollment: 14 (actual)

## Conditions studied

- Cryotherapy Effect
- Peripheral Neuropathy
- Nail Toxicity

## Interventions

- **OTHER:** cryotherapy

## Key facts

- **NCT ID:** NCT04558034
- **Lead sponsor:** Parkview Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-08-04
- **Primary completion:** 2021-02-03
- **Final completion:** 2021-02-03
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Principal Investigator retired before study completed.
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04558034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04558034, "The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04558034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*